These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25811459)

  • 1. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
    Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
    PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
    Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
    BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
    Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
    J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
    Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
    Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
    Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
    J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.
    Deville JL; Gravis G; Salem N; Savoie PH; Esterni B; Walz J; Thomas P; Goncalves A; Viens P; Bladou F
    Eur J Cancer Care (Engl); 2010 Nov; 19(6):827-32. PubMed ID: 19708949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
    Siesing C; Sorbye H; Dragomir A; Pfeiffer P; Qvortrup C; Pontén F; Jirström K; Glimelius B; Eberhard J
    PLoS One; 2017; 12(8):e0182512. PubMed ID: 28800641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
    Ye F; Jin P; Cai X; Cai P; Cai H
    Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brachyury oncogene is a prognostic factor in high-risk testicular germ cell tumors.
    Pinto F; Cárcano FM; da Silva ECA; Vidal DO; Scapulatempo-Neto C; Lopes LF; Reis RM
    Andrology; 2018 Jul; 6(4):597-604. PubMed ID: 29749711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
    Jonsson L; Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Eberhard J; Jirström K
    Biomark Res; 2014; 2():11. PubMed ID: 24963396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating age into International Germ Cell Consensus Classification (IGCCC): a time to move forward?
    Abdel-Rahman O
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):101-105. PubMed ID: 29115166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I non-seminomatous testicular germ-cell tumours.
    Gilbert DC; Chandler I; Summersgill B; McIntyre A; Missiaglia E; Goddard NC; Huddart RA; Shipley J
    Int J Androl; 2011 Aug; 34(4 Pt 2):e114-21; discussion e121. PubMed ID: 21615418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
    Boman K; Andersson G; Wennersten C; Nodin B; Ahlgren G; Jirström K
    Biomark Res; 2017; 5():10. PubMed ID: 28293425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management and outcome of patients with germ-cell tumours treated in the Edinburgh Cancer Centre between 1988 and 2002.
    Howard GC; Conkey DS; Peoples S; McLaren DB; Hargreave TB; Tulloch DN; Walker W; Kerr GR
    Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):435-40. PubMed ID: 16149287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group.
    Frazier AL; Rumcheva P; Olson T; Giller R; Cushing B; Cullen J; Marina N; London WB;
    Pediatr Blood Cancer; 2008 Apr; 50(4):746-51. PubMed ID: 18085675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of nonseminomatous germ cell tumors in pediatric patients and young adults - A stage group stratified analysis.
    Srivastava A; Patel HV; Koehne E; Gupta GN; Drachtman R; Pierorazio PM; Bagrodia A; Elsamra SE; Kim IY; Ghodoussipour S; Singer EA; Jang TL; Patel HD; Barone JG
    Urol Oncol; 2022 Apr; 40(4):169.e1-169.e12. PubMed ID: 35144865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer.
    Melling N; Simon R; Mirlacher M; Izbicki JR; Stahl P; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Histopathology; 2016 Jan; 68(2):191-8. PubMed ID: 25922889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1.
    Pectasides D; Papaxoinis G; Nikolaou M; Valavanis C; Aravantinos G; Fountzilas G; Tamvakis N; Pectasides E; Lekka I; Arapantoni-Dadioti P; Zizi A; Ghiconti I; Economopoulos T
    Anticancer Res; 2009 Feb; 29(2):737-44. PubMed ID: 19331230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry.
    Yap SA; Yuh LM; Evans CP; Dall'Era MA; Wagenaar RM; Cress R; Lara PN
    World J Urol; 2017 Feb; 35(2):277-283. PubMed ID: 27306686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.